Free Trial

MarketBeat Instant News Alerts

Mercurity Fintech logo with Business Services background

Insider Selling: Mercurity Fintech (NASDAQ:MFH) Insider Sells 1,000 Shares of Stock

Mercurity Fintech Holding Inc. Sponsored ADR (NASDAQ:MFH - Get Free Report) insider Wilfred Zhongkei Daye sold 1,000 shares of the stock in a transaction on Monday, October 20th. The stock was sold at an average price of $11.98, for a total transaction of $11,980.00. Following the sale, the insider directly owned 36,800 shares of the company's stock, valued at $440,864. This represents a 2.65% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

NASDAQ:MFH
Read Insider Selling: Mercurity Fintech (NASDAQ:MFH) Insider Sells 1,000 Shares of Stock
Phreesia logo with Medical background

Amy Beth Vanduyn Sells 639 Shares of Phreesia (NYSE:PHR) Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) SVP Amy Beth Vanduyn sold 639 shares of the business's stock in a transaction dated Friday, October 17th. The shares were sold at an average price of $22.36, for a total value of $14,288.04. Following the completion of the sale, the senior vice president directly owned 111,840 shares of the company's stock, valued at $2,500,742.40. The trade was a 0.57% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link.

NYSE:PHR
Read Amy Beth Vanduyn Sells 639 Shares of Phreesia (NYSE:PHR) Stock
Ginkgo Bioworks logo with Medical background

Insider Selling: Ginkgo Bioworks (NYSE:DNA) Insider Sells 1,312 Shares of Stock

Ginkgo Bioworks Holdings, Inc. (NYSE:DNA - Get Free Report) insider Steven Coen sold 1,312 shares of the company's stock in a transaction that occurred on Friday, October 17th. The shares were sold at an average price of $13.65, for a total value of $17,908.80. Following the transaction, the insider owned 6,738 shares of the company's stock, valued at approximately $91,973.70. This represents a 16.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

NYSE:DNA
Read Insider Selling: Ginkgo Bioworks (NYSE:DNA) Insider Sells 1,312 Shares of Stock
Phreesia logo with Medical background

Phreesia (NYSE:PHR) CFO Sells $19,788.60 in Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) CFO Balaji Gandhi sold 885 shares of the stock in a transaction dated Friday, October 17th. The stock was sold at an average price of $22.36, for a total transaction of $19,788.60. Following the sale, the chief financial officer owned 98,240 shares of the company's stock, valued at $2,196,646.40. This trade represents a 0.89% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

NYSE:PHR
Read Phreesia (NYSE:PHR) CFO Sells $19,788.60 in Stock
Corbus Pharmaceuticals logo with Medical background

Anne Altmeyer Sells 1,060 Shares of Corbus Pharmaceuticals (NASDAQ:CRBP) Stock

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP - Get Free Report) Director Anne Altmeyer sold 1,060 shares of the stock in a transaction on Monday, October 20th. The shares were sold at an average price of $20.50, for a total value of $21,730.00. Following the sale, the director directly owned 6,191 shares in the company, valued at $126,915.50. This trade represents a 14.62% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

NASDAQ:CRBP
Read Anne Altmeyer Sells 1,060 Shares of Corbus Pharmaceuticals (NASDAQ:CRBP) Stock
Phreesia logo with Medical background

Insider Selling: Phreesia (NYSE:PHR) General Counsel Sells 1,241 Shares of Stock

Phreesia, Inc. (NYSE:PHR - Get Free Report) General Counsel Allison Hoffman sold 1,241 shares of the company's stock in a transaction on Friday, October 17th. The stock was sold at an average price of $22.36, for a total value of $27,748.76. Following the sale, the general counsel owned 135,737 shares of the company's stock, valued at $3,035,079.32. This trade represents a 0.91% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

NYSE:PHR
Read Insider Selling: Phreesia (NYSE:PHR) General Counsel Sells 1,241 Shares of Stock

Trending News

All MarketBeat Instant News Alerts

Phibro Animal Health logo with Medical background

Phibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 700 Shares

NASDAQ:PAHC
Read Phibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 700 Shares
Phreesia logo with Medical background

Phreesia (NYSE:PHR) Insider Evan Roberts Sells 1,888 Shares

NYSE:PHR
Read Phreesia (NYSE:PHR) Insider Evan Roberts Sells 1,888 Shares
Metropolitan Bank logo with Finance background

Metropolitan Bank (NYSE:MCB) EVP Nick Rosenberg Sells 625 Shares

NYSE:MCB
Read Metropolitan Bank (NYSE:MCB) EVP Nick Rosenberg Sells 625 Shares
Phreesia logo with Medical background

Insider Selling: Phreesia (NYSE:PHR) Insider Sells 2,059 Shares of Stock

NYSE:PHR
Read Insider Selling: Phreesia (NYSE:PHR) Insider Sells 2,059 Shares of Stock
Denny's logo with Retail/Wholesale background

Denny's (NASDAQ:DENN) Insider Purchases $48,043.58 in Stock

NASDAQ:DENN
Read Denny's (NASDAQ:DENN) Insider Purchases $48,043.58 in Stock
Hagerty logo with Finance background

Insider Selling: Hagerty (NYSE:HGTY) Director Sells 8,286 Shares of Stock

NYSE:HGTY
Read Insider Selling: Hagerty (NYSE:HGTY) Director Sells 8,286 Shares of Stock
Cullinan Therapeutics logo with Medical background

Lynx1 Capital Management Lp Acquires 15,032 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock

NASDAQ:CGEM
Read Lynx1 Capital Management Lp Acquires 15,032 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock
Cytokinetics logo with Medical background

Cytokinetics (NASDAQ:CYTK) EVP Fady Ibraham Malik Sells 2,105 Shares

NASDAQ:CYTK
Read Cytokinetics (NASDAQ:CYTK) EVP Fady Ibraham Malik Sells 2,105 Shares
Hagerty logo with Finance background

Insider Selling: Hagerty (NYSE:HGTY) Director Sells 12,219 Shares of Stock

NYSE:HGTY
Read Insider Selling: Hagerty (NYSE:HGTY) Director Sells 12,219 Shares of Stock
IPG Photonics logo with Computer and Technology background

Trevor Ness Sells 1,678 Shares of IPG Photonics (NASDAQ:IPGP) Stock

NASDAQ:IPGP
Read Trevor Ness Sells 1,678 Shares of IPG Photonics (NASDAQ:IPGP) Stock
Hagerty logo with Finance background

Insider Selling: Hagerty (NYSE:HGTY) Director Sells 14,644 Shares of Stock

NYSE:HGTY
Read Insider Selling: Hagerty (NYSE:HGTY) Director Sells 14,644 Shares of Stock
Samsara logo with Computer and Technology background

Samsara (NYSE:IOT) Insider Sells $177,141.72 in Stock

NYSE:IOT
Read Samsara (NYSE:IOT) Insider Sells $177,141.72 in Stock
Ollie's Bargain Outlet logo with Consumer Staples background

Ollie's Bargain Outlet (NASDAQ:OLLI) CFO Robert Helm Sells 1,493 Shares

NASDAQ:OLLI
Read Ollie's Bargain Outlet (NASDAQ:OLLI) CFO Robert Helm Sells 1,493 Shares
Ollie's Bargain Outlet logo with Consumer Staples background

Insider Selling: Ollie's Bargain Outlet (NASDAQ:OLLI) SVP Sells 1,775 Shares of Stock

NASDAQ:OLLI
Read Insider Selling: Ollie's Bargain Outlet (NASDAQ:OLLI) SVP Sells 1,775 Shares of Stock
IPG Photonics logo with Computer and Technology background

Eugene Scherbakov Sells 2,700 Shares of IPG Photonics (NASDAQ:IPGP) Stock

NASDAQ:IPGP
Read Eugene Scherbakov Sells 2,700 Shares of IPG Photonics (NASDAQ:IPGP) Stock
Cullinan Therapeutics logo with Medical background

Insider Buying: Cullinan Therapeutics (NASDAQ:CGEM) Major Shareholder Purchases 32,217 Shares of Stock

NASDAQ:CGEM
Read Insider Buying: Cullinan Therapeutics (NASDAQ:CGEM) Major Shareholder Purchases 32,217 Shares of Stock
Enliven Therapeutics logo with Medical background

Enliven Therapeutics (NASDAQ:ELVN) CEO Samuel Kintz Sells 12,500 Shares

NASDAQ:ELVN
Read Enliven Therapeutics (NASDAQ:ELVN) CEO Samuel Kintz Sells 12,500 Shares
MBX Biosciences logo with Manufacturing background

MBX Biosciences (NASDAQ:MBX) CEO Acquires $272,800.00 in Stock

NASDAQ:MBX
Read MBX Biosciences (NASDAQ:MBX) CEO Acquires $272,800.00 in Stock
Vor Biopharma logo with Manufacturing background

Reprogrammed Interchange Llc Sells 11,616 Shares of Vor Biopharma (NASDAQ:VOR) Stock

NASDAQ:VOR
Read Reprogrammed Interchange Llc Sells 11,616 Shares of Vor Biopharma (NASDAQ:VOR) Stock
Cullinan Therapeutics logo with Medical background

Lynx1 Capital Management Lp Acquires 51,500 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock

NASDAQ:CGEM
Read Lynx1 Capital Management Lp Acquires 51,500 Shares of Cullinan Therapeutics (NASDAQ:CGEM) Stock
Salesforce logo with Computer and Technology background

Marc Benioff Sells 2,250 Shares of Salesforce (NYSE:CRM) Stock

NYSE:CRM
Read Marc Benioff Sells 2,250 Shares of Salesforce (NYSE:CRM) Stock
Argan logo with Construction background

Argan (NYSE:AGX) Director Sells $584,000.00 in Stock

NYSE:AGX
Read Argan (NYSE:AGX) Director Sells $584,000.00 in Stock
Aeluma logo with Manufacturing background

Aeluma (NASDAQ:ALMU) Major Shareholder Mark Tompkins Sells 37,500 Shares

NASDAQ:ALMU
Read Aeluma (NASDAQ:ALMU) Major Shareholder Mark Tompkins Sells 37,500 Shares
Phibro Animal Health logo with Medical background

Phibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 16,075 Shares

NASDAQ:PAHC
Read Phibro Animal Health (NASDAQ:PAHC) CEO Jack Bendheim Sells 16,075 Shares